Time to treatment intensification in patients on dual pharmacotherapy for type 2 diabetes

被引：0
|
作者：
Roberto, Giuseppe [1 ]
Barone-Adesi, Francesco [2 ]
Giorgianni, Francesco [3 ]
Pizzimenti, Valeria [3 ]
Bartolini, Claudia [1 ]
Magnani, Corrado [4 ]
Maggini, Marina [5 ]
Da Cas, Roberto [5 ]
Spila-Alegiani, Stefania [5 ]
Ferrajolo, Carmen [6 ,7 ]
Francesconi, Paolo [1 ]
Trifiro, Gianluca [3 ]
Poluzzi, Elisabetta [8 ]
Baccetti, Fabio [9 ]
Gini, Rosa [1 ]
机构：
[1] Agenzia Reg Sanita Toscana, Florence, Italy
[2] Univ Piemonte Orientale, Dept Pharmaceut Sci, Novara, Italy
[3] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Messina, Italy
[4] Univ Piemonte Orientale, Dept Translat Med, Novara, Italy
[5] Italian Natl Inst Hlth, Natl Ctr Epidemiol, Rome, Italy
[6] Univ Campania Luigi Vanvitelli, Dept Expt Med, Unit Clin Pharmacol, Campania Reg Ctr Pharmacovigilance & Pharmacoepid, Naples, Italy
[7] Erasmus MC Univ, Dept Med Informat, Rotterdam, Netherlands
[8] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy
[9] Local Hlth Author Toscana Nordovest, Dept Diabetol, Carrara, Italy
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2018年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
390
引用
收藏
页码：180 / 180
页数：1
相关论文
共 50 条
  • [1] Treatment intensification in patients with type 2 diabetes
    Barnett, Anthony H.
    DIABETES OBESITY & METABOLISM, 2008, 10 : III - III
  • [2] Pharmacotherapy of "treatment resistant' type 2 diabetes
    Scheen, Andre J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (05) : 503 - 515
  • [3] Treatment intensification for patients with type 2 diabetes and poor glycaemic control
    Fu, A. Z.
    Sheehan, J. J.
    DIABETES OBESITY & METABOLISM, 2016, 18 (09): : 892 - 898
  • [4] Time to treatment intensification and its association with subsequent microvascular outcomes among patients with type 2 diabetes
    Desai, U.
    Kirson, N. Y.
    Kim, J.
    Khunti, K. K.
    King, S. B.
    Trieschman, E.
    Hellstern, M.
    Hunt, P. R.
    Mukheijee, J.
    DIABETOLOGIA, 2016, 59 : S488 - S488
  • [5] Time to treatment intensification and its association with subsequent macrovascular outcomes among patients with type 2 diabetes
    Kim, J.
    Desai, U.
    Kirson, N. Y.
    King, S. B.
    Trieschman, E.
    Hellstern, M.
    Hunt, P. R.
    Mukherjee, J.
    DIABETOLOGIA, 2016, 59 : S29 - S30
  • [6] Time to Treatment Intensification and Its Association with Subsequent Glycemic Control among Patients with Type 2 Diabetes
    Desai, Urvi
    Kirson, Noam Y.
    Kim, Jennifer
    Khunti, Kamlesh
    King, Sarah B.
    Trieschman, Erich
    Hellstern, Michael
    Hunt, Phillip R.
    Mukherjee, Jayanti
    DIABETES, 2016, 65 : A319 - A320
  • [7] DE-INTENSIFICATION OF DIABETES TREATMENT IN ELDERLY PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Pirela, Daniela, V
    Garg, Rajesh
    ENDOCRINE PRACTICE, 2019, 25 (12) : 1317 - 1322
  • [8] Pharmacotherapy for the treatment of patients with type 2 diabetes mellitus: Rationale and specific agents
    Cefalu, W. T.
    Waldman, S.
    Ryder, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (05) : 636 - 649
  • [9] The Efficacy of Pharmacotherapy in the Treatment of Obesity in Patients With Type 2 Diabetes: A Systematic Review
    Alshahrani, Omar
    Almalki, Mohammed S.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [10] Trends in Insulin Initiation and Treatment Intensification Among Patients With Type 2 Diabetes
    Patrick, Amanda R.
    Fischer, Michael A.
    Choudhry, Niteesh K.
    Shrank, William H.
    Seeger, John D.
    Liu, Jun
    Avorn, Jerry
    Polinski, Jennifer M.
    DIABETES, 2013, 62 : A323 - A324
12345